|Day Low/High||0.42 / 0.45|
|52 Wk Low/High||0.31 / 2.57|
Expected to Expand Global Availability of Farnesene for Variety of Applications
Strongest Operational Execution to Date while Successfully Moving the Business Beyond Biofuels
ARG Joins Amyris and Cosan with Equity Investment and Market Access to Accelerate Revenue Growth of Novvi High Performance, Sustainably Sourced, Renewable Lubricant Products
But in a narrow field, finding suppliers may be an issue.
Two Year Committed Jet Fuel Supply Deal Demonstrating Continued Strong Farnesene Demand
Gen9 and Amyris today announced an agreement for the supply of multiple megabases of synthetic DNA content.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Provides Secure Supply for Highly Disruptive Nutraceutical Product
Recognized in Diagnostics & Disease Treatment Category Showcasing BioPharma Collaborative Excellence